查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2046206

手術機器人市場－全球產業規模、佔有率、趨勢、機會、預測：按類型、應用、最終用戶、地區、競爭格局分類，2021-2031年

Surgical Robotics Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Type, By Application, By End User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球手術機器人市場預計將從 2025 年的 100.2 億美元大幅成長至 2031 年的 171.1 億美元，複合年成長率達 9.33%。

這些專用電子機械系統旨在幫助醫療專業人員以更高的精確度、靈活性和控制力進行微創手術。推動這一成長的主要因素是全球慢性病盛行率的上升和人口老化，這反過來又導致需要更頻繁的醫療干預，以縮短恢復時間並減少術後併發症。國際機器人聯合會 (IFR) 的數據顯示，到 2024 年，手術機器人的需求將增加 41%，這印證了上述趨勢。此外，機器人輔助手術領域的持續技術創新正在加速市場發展，例如，引入了具有先進觸覺回饋、更佳可視性和數據驅動洞察等功能的系統，從而克服了傳統技術的局限性。這些技術改進的快速普及體現在直覺外科公司（Intuitive Surgical）在2024年部署了362套達文西5手術系統，這助力Medtronic）的醫療外科產品組合在2024年11月實現了21.3億美元的全球銷售額。同時，對縮短住院時間和最大限度減少併發症的迫切需求正在推動市場擴張，因為微創手術的需求不斷成長，機器人輔助手術也逐漸成為標準選擇。例如，2024年全球達文西手術的數量增加了約17%。

市場概覽
預測期 2027-2031
市場規模：2025年 100.2億美元
市場規模：2031年 171.1億美元
複合年成長率：2026-2031年 9.33%
成長最快的細分市場 泌尿系統手術
最大的市場 北美洲

市場促進因素

機器人輔助手術領域的技術創新是推動市場發展的主要動力，這些創新引入了具備先進觸覺回饋、更佳可視性和數據驅動洞察的系統。這些新世代平台克服了傳統手術在操作性和感官回饋方面的局限性，促進了致力於提供尖端醫療服務的醫療機構的廣泛應用。例如，力感測器技術的整合提高了複雜解剖手術的精準度，加速了老舊設備的更新換代。根據直覺外科公司（Intuitive Surgical）於2025年1月發布的2024年第四季及全年快報業績報告，該公司在2024年交付了362套達文西5手術系統，這表明業界正在快速向這些增強型系統轉型。領導企業的雄厚財力也進一步支撐了這項技術發展動能。根據美敦力公司（Medtronic）於2024年11月發布的2025年第二季業績報告，其醫療手術產品組合的全球銷售額達到21.3億美元，反映了先進手術解決方案帶來的巨大市場價值。微創手術需求的不斷成長，主要源於縮短住院時間和減少術後併發症等關鍵需求，同時也推動了市場成長。隨著病患意識的提高以及醫療機構致力於最佳化床位利用率，機器人輔助手術正逐漸成為包括一般外科和胸腔外科在內的多種適應症的首選治療方法。這一轉變體現在全球手術量的激增上，因為醫院優先考慮能夠確保臨床療效穩定和提高患者周轉率的技術。根據直覺外科公司（Intuitive Surgical）於2025年1月發布的2024年第四季及全年快報業績報告，2024年全球達文西手術量年增約17%，這直接印證了臨床對機器人手術日益成長的依賴。

市場挑戰

儘管成長顯著，但手術機器人系統部署和維護的高昂資本成本仍是阻礙其進一步市場滲透的主要障礙。這使得手術機器人系統主要局限於資金雄厚的大規模大學醫院和私人醫療機構。除了持續的維護、專業培訓和一次性器械支出外，這種資金限制還需要大量的初始投資。預計到2025年，機器人關節重建平台的初始部署成本將在50萬至100萬美元之間，這將限制成本敏感地區的小規模醫療機構和診所獲得該技術，從而阻礙其普及並延緩傳統設備的更新換代。手術機器人系統部署和維護的高昂資本成本是市場進入和擴張的主要障礙。這種資金限制直接阻礙了全球手術機器人市場的成長，因為它將部署限制在資金雄厚的大規模大學醫院和私人醫療機構，實際上將小規模醫院和門診手術中心排除在外。巨額的初始投資加重了醫療機構的資本支出預算負擔，尤其是在成本敏感地區和開發中國家。因此，許多醫療機構被迫放棄採用這些先進技術，轉而選擇成本較低的傳統手術方法，這限制了全球整體機器人手術的總數，並減緩了傳統設備的更新換代速度。此外，經濟負擔不僅限於初始購置成本；醫療機構還必須考慮與系統維護、專業培訓和一次性器械更換相關的巨額持續成本。對於患者數量較少的醫院而言，這些持續支出會改變成本效益平衡，使其難以證明投資回報的合理性。根據美國整形外科學會 (AAOS) 預測，到 2025 年，機器人關節重建平台的初始投資成本（不包括維護和一次性配件的額外成本）通常在 50 萬至 100 萬美元之間。如此高昂的價格阻礙了這項技術的廣泛應用，抑制了市場滲透，並使其僅限於整個醫療產業的一小部分，從而限制了該行業的成長潛力。

市場趨勢

然而，關鍵發展正推動市場迎來變革性轉變。人工智慧驅動的預測分析和決策支援的融合，正將機器人平台轉變為積極主動的認知夥伴，提供術中指導，並將其目標市場拓展至傳統應用之外。例如，新核准的系統每年可處理1,880萬例軟組織手術，而現有遠端機器人系統目前尚無法勝任。同時，5G賦能的遠端手術和遠端操作技術的進步正在克服傳統的延遲障礙。這使得遠端機器人手術借助超可靠的高頻寬網路成為臨床現實。例如，2024年3月，一項成功的遠端手術將奧蘭多的外科醫生與杜拜的主機連接起來，兩地相距超過1萬公里。人工智慧驅動的預測分析和決策支援的融合，正將機器人平台從被動工具轉變為積極主動的認知夥伴。製造商正將即時機器學習演算法直接整合到手術主機中，以提供術中指導並識別解剖結構，從而最佳化以往服務不足的適應症的手術流程。向智慧機器人技術的轉變正在加速複雜軟組織手術的標準化，並有效地將這項技術的市場拓展到傳統泌尿系統和婦科應用之外。根據2024年6月《醫療產品外包》（Medical Product Outsourcing）雜誌上報導“Moon Surgical公司的商用Maestro機器人獲得FDA核准”的文章，這款新核准的系統旨在每年完成1880萬例現有遠程機器人系統無法覆蓋的軟組織手術，展現了人工智慧整合平台在普通外科這一高容量平台的巨大潛力。同時，5G賦能的遠端手術和遠端控制技術的進步正在克服傳統的延遲障礙，使遠端機器人輔助手術成為臨床現實。超高可靠性、高頻寬網路的引入，使外科醫生能夠為地理位置遙遠的患者進行手術，並獲得來自手術器械的即時回饋，從而使偏遠和醫療資源匱乏地區的患者也能獲得專業的醫療服務。這項技術正迅速從實驗測試階段過渡到實際應用階段，凸顯了下一代連接技術在關鍵醫療服務的可靠性。根據愛立信2024年3月發布的報告《擺脫線纜束縛：5G時代的遠程救命手術》，一個外科團隊成功進行了遠程手術直播，將佛羅裡達州奧蘭多的外科醫生與杜拜的主機連接起來，兩地相距超過1萬公里。這有效地證明了跨洲手術的可行性。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球手術機器人市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 按類型（手術系統、器械/配件、服務）
    • 依應用領域（一般外科、泌尿系統、婦科、整形外科、心血管手術外科、頭頸外科（包括神經外科）、其他）
    • 依最終使用者（醫院、門診手術中心等）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美手術機器人市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲手術機器人市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區手術機器人市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲手術機器人市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲手術機器人市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球手術機器人市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Asensus Surgical, Inc.
  • Siemens Healthineers AG
  • Brainlab AG
  • CMR Surgical Ltd.
  • Curexo, Inc.
  • Globus Medical, Inc.
  • Smith & Nephew plc
  • Intuitive Surgical, Inc.
  • Johnson & Johnson
  • Kinova inc.
  • Medtronic plc

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 16525

The Global Surgical Robotics Market is projected to expand significantly from USD 10.02 Billion in 2025 to USD 17.11 Billion by 2031, achieving a robust 9.33% CAGR. These specialized electromechanical systems are designed to assist medical professionals in performing minimally invasive procedures with enhanced precision, dexterity, and control. This growth is primarily fueled by the increasing prevalence of chronic diseases and a growing aging population globally, which necessitates frequent medical interventions offering shorter recovery times and reduced postoperative complications, as evidenced by a 41% surge in demand for surgical robots in 2024 according to the International Federation of Robotics. Further catalyzing market evolution are continuous technological innovations in robotic-assisted surgery, introducing systems with advanced haptic feedback, improved visualization, and data-driven insights that address previous limitations. The rapid adoption of these enhanced capabilities is demonstrated by Intuitive Surgical's placement of 362 da Vinci 5 systems in 2024, contributing to Medtronic's Medical Surgical Portfolio achieving $2.13 billion in global revenue by November 2024. Concurrently, the rising demand for minimally invasive surgical procedures, driven by the critical need to reduce hospital stays and minimize complications, is propelling market expansion, making robotic-assisted interventions a preferred standard; worldwide da Vinci procedures, for instance, grew approximately 17% in 2024.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 10.02 Billion
Market Size 2031USD 17.11 Billion
CAGR 2026-20319.33%
Fastest Growing SegmentUrology Surgery
Largest MarketNorth America

Market Driver

Technological Innovations in Robotic-Assisted Surgery are acting as a primary catalyst for market evolution, introducing systems with advanced haptic feedback, improved visualization, and data-driven insights. These next-generation platforms address previous limitations regarding dexterity and sensory feedback, encouraging broader adoption by healthcare institutions aiming for state-of-the-art care. For instance, the integration of force-sensing technology allows for greater surgical confidence during complex dissections, accelerating the replacement of older units. According to Intuitive Surgical, January 2025, in the 'Preliminary Fourth Quarter and Full Year 2024 Results', the company placed 362 da Vinci 5 systems in 2024, demonstrating the industry's rapid transition toward these enhanced capabilities. This technological momentum is further evidenced by the financial scale of major players; according to Medtronic, November 2024, in the 'Second Quarter Fiscal 2025 Financial Results', the Medical Surgical Portfolio achieved global revenue of $2.13 billion, reflecting the substantial market value driven by advanced surgical solutions. The Increasing Demand for Minimally Invasive Surgical Procedures is simultaneously propelling market growth, driven by the critical need to reduce hospital stays and minimize postoperative complications. As patient awareness grows and healthcare providers seek to optimize bed utilization, robotic-assisted interventions are becoming the preferred standard for a widening range of indications, including general and thoracic surgeries. This shift is quantitatively visible in the surging volume of operations performed globally, as hospitals prioritize technologies that ensure consistent clinical outcomes and faster patient turnover. According to Intuitive Surgical, January 2025, in the 'Preliminary Fourth Quarter and Full Year 2024 Results', worldwide da Vinci procedures grew approximately 17% in 2024 compared to the previous year, directly validating the intensifying reliance on robotic modalities to meet clinical demand.

Market Challenge

Despite this substantial growth, a significant challenge impeding broader market penetration is the high capital cost associated with acquiring and maintaining surgical robotic systems, which primarily limits adoption to large, well-funded academic medical centers and private institutions. This financial constraint, requiring substantial upfront investment and ongoing expenditures for maintenance, specialized training, and disposable instruments-with initial acquisition costs for robotic arthroplasty platforms typically ranging from $500,000 to $1 million in 2025-restricts accessibility for smaller healthcare facilities and institutions in cost-sensitive regions, thus preventing universal reach and slowing the replacement of conventional equipment. The high capital cost associated with acquiring and maintaining surgical robotic systems serves as a substantial barrier to market entry and expansion. This financial constraint directly hampers the growth of the global surgical robotics market by limiting adoption to large, well-funded academic medical centers and private institutions, while effectively excluding smaller hospitals and ambulatory surgical centers. The requirement for a massive upfront investment strains the capital expenditure budgets of healthcare facilities, particularly in cost-sensitive regions or developing economies. Consequently, many providers are forced to forgo these advanced technologies in favor of traditional, less expensive surgical methods, which restricts the overall volume of robotic procedures performed worldwide and slows the replacement rate of conventional equipment. Furthermore, the financial burden extends beyond the initial purchase, as facilities must account for significant recurring costs related to system maintenance, specialized training, and disposable instrument replacement. This ongoing expenditure alters the cost-benefit ratio for hospitals with lower patient volumes, making the return on investment difficult to justify. According to the American Academy of Orthopaedic Surgeons, in 2025, the initial acquisition cost for robotic arthroplasty platforms typically ranged between $500,000 and $1 million, excluding additional expenses for maintenance and disposable accessories. Such prohibitive pricing structures prevent the technology from achieving universal reach, thereby stalling broader market penetration and confining the industry's growth potential to a fraction of the total available healthcare sector.

Market Trends

However, the market is poised for transformative change through key trends. The integration of AI-driven predictive analytics and decision support is evolving robotic platforms into active cognitive partners, providing intraoperative guidance and expanding their addressable market beyond traditional applications; for example, a newly cleared system targets 18.8 million annual soft tissue surgical procedures not currently addressed by existing telerobotic systems. Simultaneously, the advancement of 5G-enabled telesurgery and remote operations is overcoming historic latency barriers, making long-distance robotic intervention a clinical reality through ultra-reliable, high-bandwidth networks, as demonstrated by a successful live remote telesurgery connecting a surgeon in Orlando to a console in Dubai across over 10,000 kilometers in March 2024. The Integration of AI-Driven Predictive Analytics and Decision Support is transitioning robotic platforms from passive tools into active cognitive partners. Manufacturers are embedding real-time machine learning algorithms directly into surgical consoles to provide intraoperative guidance and identify anatomical structures, thereby optimizing workflows for previously underserved indications. This shift towards intelligent robotics facilitates the standardization of complex soft tissue procedures, effectively expanding the technology's addressable market beyond traditional urology and gynecology applications. According to Medical Product Outsourcing, June 2024, in the 'Moon Surgical's Commercial Maestro Robot Wins FDA Nod' article, the newly cleared system targets the 18.8 million annual soft tissue surgical procedures not currently addressed by existing telerobotic systems, illustrating the immense potential of AI-integrated platforms to capture high-volume general surgery segments. Simultaneously, the Advancement of 5G-Enabled Telesurgery and Remote Operations is overcoming historic latency barriers, making long-distance robotic intervention a clinical reality. The deployment of ultra-reliable, high-bandwidth networks enables surgeons to operate on patients across vast geographical divides with immediate instrument responsiveness, democratizing access to specialized care in remote or underserved regions. This capability is rapidly moving from experimental trials to practical demonstration, validating the reliability of next-generation connectivity in critical healthcare delivery. According to Ericsson, March 2024, in the 'Cutting the cord: Lifesaving telesurgery in the age of 5G' report, a surgical team successfully conducted a live remote telesurgery connecting a surgeon in Orlando, Florida to a console in Dubai, spanning a distance of over 10,000 kilometers, effectively proving the viability of transcontinental operations.

Key Market Players

  • Asensus Surgical, Inc.
  • Siemens Healthineers AG
  • Brainlab AG
  • CMR Surgical Ltd.
  • Curexo, Inc.
  • Globus Medical, Inc.
  • Smith & Nephew plc
  • Intuitive Surgical, Inc.
  • Johnson & Johnson
  • Kinova inc.
  • Medtronic plc

Report Scope

In this report, the Global Surgical Robotics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Surgical Robotics Market, By Type

  • Surgical Systems
  • Instruments and Accessories
  • Services

Surgical Robotics Market, By Application

  • General Surgery
  • Urology Surgery
  • Gynecology Surgery
  • Orthopedic Surgery
  • Cardiology Surgery
  • Head and Neck (including Neurology) Surgery
  • others

Surgical Robotics Market, By End User

  • Hospitals
  • Ambulatory Surgery Centers
  • Others

Surgical Robotics Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Surgical Robotics Market.

Available Customizations:

Global Surgical Robotics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Surgical Robotics Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Surgical Systems, Instruments and Accessories, Services)
    • 5.2.2. By Application (General Surgery, Urology Surgery, Gynecology Surgery, Orthopedic Surgery, Cardiology Surgery, Head and Neck (including Neurology) Surgery, others)
    • 5.2.3. By End User (Hospitals, Ambulatory Surgery Centers, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Surgical Robotics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Application
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Surgical Robotics Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Surgical Robotics Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Surgical Robotics Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End User

7. Europe Surgical Robotics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Application
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Surgical Robotics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End User
    • 7.3.2. France Surgical Robotics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End User
    • 7.3.3. United Kingdom Surgical Robotics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End User
    • 7.3.4. Italy Surgical Robotics Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Surgical Robotics Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End User

8. Asia Pacific Surgical Robotics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Application
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Surgical Robotics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End User
    • 8.3.2. India Surgical Robotics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End User
    • 8.3.3. Japan Surgical Robotics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Surgical Robotics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Surgical Robotics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End User

9. Middle East & Africa Surgical Robotics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Application
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Surgical Robotics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End User
    • 9.3.2. UAE Surgical Robotics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End User
    • 9.3.3. South Africa Surgical Robotics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End User

10. South America Surgical Robotics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Application
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Surgical Robotics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End User
    • 10.3.2. Colombia Surgical Robotics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End User
    • 10.3.3. Argentina Surgical Robotics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Surgical Robotics Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Asensus Surgical, Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Siemens Healthineers AG
  • 15.3. Brainlab AG
  • 15.4. CMR Surgical Ltd.
  • 15.5. Curexo, Inc.
  • 15.6. Globus Medical, Inc.
  • 15.7. Smith & Nephew plc
  • 15.8. Intuitive Surgical, Inc.
  • 15.9. Johnson & Johnson
  • 15.10. Kinova inc.
  • 15.11. Medtronic plc

16. Strategic Recommendations

17. About Us & Disclaimer